Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 6/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16283129 | 0.96 | — | — | |
| SCHEMBL16281909 | 0.89 | ALDH1A1 (0.33) | ALDH1A1ATMHPGDL3MBTL1TSHR | |
| SCHEMBL15025747 | 0.86 | — | — | |
| SCHEMBL16281912 | 0.81 | PPARG (0.41) | ALDH1A1ATMHPGDL3MBTL1TSHR | |
| SCHEMBL16281913 | 0.78 | — | — | |
| SCHEMBL15025260 | 0.78 | PPARG (0.38) | ALDH1A1ATMHPGDL3MBTL1TSHR | |
| SCHEMBL16281910 | 0.78 | ADORA2B (0.36) | ALDH1A1ATMHPGDL3MBTL1TSHR | |
| SCHEMBL16281914 | 0.77 | L3MBTL1 (0.33) | ALDH1A1ATMHPGDL3MBTL1TSHR | |
| SCHEMBL15025583 | 0.76 | L3MBTL1 (0.34) | ALDH1A1ATMHPGDL3MBTL1KDM4E | |
| SCHEMBL15025630 | 0.75 | HPGD (0.31) | ATMHPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321792-B2 | Hydrolysable silanes | DOW CORNING CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140364627-A1 | Hydrolysable Silanes | DOW SILICONES CORPORATION | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364627-A1 | Hydrolysable Silanes | ESD, JMJD6, KDM5A | ALDH1A1 376/4885ATM 3332/4885HPGD 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.